Patents by Inventor Mehrnoush Khojasteh

Mehrnoush Khojasteh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11941861
    Abstract: Disclosed herein are systems and methods of estimating the autofluorescence (AF) signal and other non-target signals in each channel of a multi-channel image of a biological sample that is stained with one or more fluorescent labels. In some embodiments, the estimated autofluorescence signal can then be subtracted or masked from the multi-channel image. In some embodiments, the autofluorescence-removed multichannel image can then be use for further processing (e.g. image analysis, etc.).
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: March 26, 2024
    Assignee: VENTANA MEDICAL SYSTEMS, INC.
    Inventors: Joerg Bredno, Mehrnoush Khojasteh, Ilya Ravkin, Smadar Shiffman, Xingwei Wang
  • Publication number: 20230169406
    Abstract: A machine learning model is accessed that is configured to use one or more parameters to process images to generate labels. The machine learning model is executed to transform at least part of each of at least one digital pathology image into a plurality of predicted labels; and generate a confidence metric for each of the plurality of predicted labels. An interface is availed that depicts the at least part of the at least one digital pathology image and that differentially represents predicted labels based on corresponding confidence metrics. In response to availing of the interface, label input is received that confirms, rejects, or replaces at least one of the plurality of predicted labels. The one or more parameters of the machine learning model are updated based on the label input.
    Type: Application
    Filed: January 31, 2023
    Publication date: June 1, 2023
    Applicant: VENTANA MEDICAL SYSTEMS, INC.
    Inventors: Hadley Fellows, Mehrnoush Khojasteh, Justine Larsen, Jim F. Martin, Nidhin Murari, Fahime Sheikhzadeh
  • Publication number: 20230081277
    Abstract: Efficient methods for identifying biomarkers are described. The method may include identifying a tumor area. The method may further include identifying a plurality of regions. The method may also include defining, for each region, a bounding area for the region that encompasses the region. The method may include determining, for each region of a first subset of the plurality of regions, that the region is to be ascribed to the tumor, where the bounding area is fully within the tumor area. The method may further include determining, for each region of a second subset of the plurality of regions, whether to ascribe the region to the tumor based on an intersection of the region and the tumor area. The method may also include accessing a metric characterizing a biological observation and generating a result based on the metrics. The result may be used as a biomarker.
    Type: Application
    Filed: April 22, 2021
    Publication date: March 16, 2023
    Applicant: Ventana Medical Systems, Inc.
    Inventors: Xingwei Wang, Mehrnoush Khojasteh, Yao Nie, Jim F. Martin, Wenjun Zhang
  • Publication number: 20210397870
    Abstract: Disclosed herein are systems and methods of estimating the autofluorescence (AF) signal and other non-target signals in each channel of a multi-channel image of a biological sample that is stained with one or more fluorescent labels. In some embodiments, the estimated autofluorescence signal can then be subtracted or masked from the multi-channel image. In some embodiments, the autofluorescence-removed multichannel image can then be use for further processing (e.g. image analysis, etc.).
    Type: Application
    Filed: August 6, 2021
    Publication date: December 23, 2021
    Applicant: VENTANA MEDICAL SYSTEMS, INC.
    Inventors: Joerg Bredno, Mehrnoush Khojasteh, Ilya Ravkin, Smadar Shiffman, Xingwei Wang
  • Publication number: 20210374962
    Abstract: A scoring functions is developed and used for identifying patients who might be responsive to a PD-1 axis directed therapy. The scoring functions are obtained by extracting features from multiplex-stained sections, selecting features that correlate with response to the therapy using a feature selection function, and fitting one or more of the selected features to a plurality of candidate scoring functions. A candidate scoring function showing the desired balance between predictive sensitivity and specificity may then selected for incorporation into a scoring system that includes at least an image analysis system.
    Type: Application
    Filed: March 30, 2021
    Publication date: December 2, 2021
    Inventors: Mehrnoush KHOJASTEH, Jim F. MARTIN, Lidija PESTIC-DRAGOVICH, Lei TANG, Xiangxue WANG, Wenjun ZHANG, Robert ANDERS, Luis DIAZ
  • Patent number: 8559693
    Abstract: Systems and methods for the quantitative automated analysis of pathology samples identify groups of spatially-associated similar cells. Cells may be identified as belonging to a group on the basis of spatial location and biomarkers. In some embodiments the biomarkers are multicolour fluorescence in situ hybridization (FISH) signals. Characteristics of the cells in a group may be combined to provide quantitative FISH results that may compensate for variations and artefacts such as thin sectioning that can result in the loss of information due to damage. In heterogeneous tissue samples, grouping cells can permit quantitative results regarding pathological cells to be extracted despite the presences of infiltrating non pathological cells.
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: October 15, 2013
    Assignees: British Columbia Cancer Agency Branch, The University of British Columbia
    Inventors: Calum Eric MacAulay, Piotr Dubrowski, Martial Guillaud, Mehrnoush Khojasteh
  • Publication number: 20120061590
    Abstract: Imaging methods and apparatus may be applied to image tissues as well as other areas. A computer-controlled color-selectable light source is controlled to emit light having a desired spectral profile and to illuminate an area. An imaging detector images the illuminated area. The spectral profile may be selected to yield images in which contrast between features of interest and other features is enhanced. The images may be combined into a composite image. In some embodiments the spectral profile is based on a principal components analysis such that the images each correspond to one principal component.
    Type: Application
    Filed: May 21, 2010
    Publication date: March 15, 2012
    Applicant: British Columbia Cancer Agency Branch
    Inventors: Mehrnoush Khojasteh, Calum Eric Macaulay